Patents Assigned to Taipei City Hospital
  • Patent number: 9144414
    Abstract: The present invention relates to a method for quantifying drug delivery with the characteristic of measuring the signal intensity of peripheral vessels with a contrast-enhanced ultrasound to quantify the drug delivery at a target site. The present invention can be used for quantifying UTMD (ultrasound triggered microbubble destruction) targeted drug delivery, also for qualifying the unreleased amount of the long-acting drug in the tested object, and for helping setting the treatment schedule for ultrasound disruption of blood-brain barrier.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: September 29, 2015
    Assignee: Taipei City Hospital
    Inventors: Shuo-Hui Hung, Ran-Chou Chen, Tung-Hu Tsai